<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) shares advanced in Thursday’s early deals as the ArtemiC Rescue product is granted import approval in India, opening a potentially significant new market for the company. ArtemiC Rescue, a nutraceutical product proven (in a Phase II clinical trial) to help alleviate symptoms associated with COVID-19, has been approved by Indian regulators for import, distribution, marketing, and sales.
...read full article on Proactive Investors
